Given Imaging Second Quarter 2002 Revenues Exceed $7 Million

Yoqneam, Israel - July 16, 2002 - Given Imaging (NASDAQ: GIVN) announced today that sales of its Given Diagnostic System and M2A® capsule endoscope exceeded $7 million in the second quarter of 2002.

Second Quarter Conference Call Details

Given Imaging plans to release second quarter 2002 financial results following the close of market trading on Wednesday, July 31, 2002. The Company will host a conference call on Thursday, August 1 at 11:00am Eastern time, 6:00pm Israel time, which will be broadcast live on Given Imaging’s website, www.givenimaging.com.

This press release contains forward-looking statements, including projections about our business, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. For example, statements in the future tense, words such as "anticipates," "estimates," "expects," "intends," "plans," "believes," "intends" and words and terms of similar substance used in connection with any discussion of future operating or financial performance identify such forward-looking statements. Those forward-looking statements are not guarantees of future performance and actual results could differ materially from our current expectations as a result of numerous factors, including but not limited to the following: changes in regulatory environment, our success in implementing our sales, marketing and manufacturing plan, protection and validity of patents and other intellectual property rights, the impact of currency exchange rates, the effect of competition by other companies, the outcome of future litigation, the reimbursement policies for our product from healthcare payors, and other risks disclosed in our filings with the U.S. Securities Exchange Commission.

19.Sept.'03